| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| NLRP3/AIM2-IN-2 |
化合物 NLRP3/AIM2-IN-2 |
791840-86-3 |
詳細(xì)
|
| N-Boc-Phe-Leu-Phe-Leu-Phe |
N-Boc-Phe-Leu-Phe-Leu-Phe |
148182-34-7 |
詳細(xì)
|
| NS2B/NS3-IN-3 |
化合物 NS2B/NS3-IN-3 |
2832876-90-9 |
詳細(xì)
|
| NU6300 |
NU6300 |
2070015-09-5 |
詳細(xì)
|
| NRC-2694 |
936446-61-6 |
936446-61-6 |
詳細(xì)
|
| 4-Nonylphenol-d5 |
4-N-NONYLPHENOL-2,3,5,6-D4,OD |
358730-95-7 |
詳細(xì)
|
| β-Neo-Endorphin |
TYR-GLY-GLY-PHE-LEU-ARG-LYS-TYR-PRO: YGGFLRKYP |
77739-21-0 |
詳細(xì)
|
| Nateglinide-d5 |
那格列奈-D5 |
1227666-13-8 |
詳細(xì)
|
| NVS-SM2 |
Phenol, 2-[6-[methyl(2,2,6,6-tetramethyl-4-piperidinyl)amino]-3-pyridazinyl]-5-(1H-pyrazol-4-yl)- |
1562333-92-9 |
詳細(xì)
|
| NF-κΒ activator 1 |
化合物NF-ΚΒ ACTIVATOR 1 |
2387524-59-4 |
詳細(xì)
|
| Nemorubicin |
奈莫柔比星 |
108852-90-0 |
詳細(xì)
|
| NLRP3-IN-11 |
化合物 NLRP3-IN-11 |
2769040-91-5 |
詳細(xì)
|
| NSC639828 |
NSC 639828 |
134742-26-0 |
詳細(xì)
|
| NSP-805 |
125068-54-4 |
125068-54-4 |
詳細(xì)
|
| N-Nornuciferine |
N-去甲荷葉堿 |
4846-19-9 |
詳細(xì)
|
| NSP-AS |
吖啶鹽NSP-SA |
211106-69-3 |
詳細(xì)
|
| Namitecan |
372105-27-6 |
372105-27-6 |
詳細(xì)
|
| NCGC00229600 |
4(1H)-Quinazolinone, 2-[3-[(2,6-diMethylphenoxy)Methyl]-4-Methoxyphenyl]-2,3-dihydro-3-(3-pyridinylMethyl)- |
1338824-20-6 |
詳細(xì)
|
| NHE3-IN-2 |
N-(6-氯-4-苯基喹唑啉-2-基)胍 |
92434-13-4 |
詳細(xì)
|
| Nav1.7-IN-2 |
1332295-35-8 |
1332295-35-8 |
詳細(xì)
|
| N3-PEG3-CH2CH2COOH |
疊氮-三乙二醇-丙酸 |
1056024-94-2 |
詳細(xì)
|
| Nelonemdaz potassium |
916214-57-8 |
916214-57-8 |
詳細(xì)
|
| NFAT Transcription Factor Regulator-1 |
245747-71-1 |
245747-71-1 |
詳細(xì)
|
| NAMPT inhibitor-linker 1 |
NAMPT INHIBITOR-LINKER 1 |
2241019-57-6 |
詳細(xì)
|
| NVP-BHG712 isomer |
NVP-BHG712 isomer |
2245892-85-5 |
詳細(xì)
|
| NBDHEX |
1-Hexanol, 6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)thio]- |
787634-60-0 |
詳細(xì)
|
| Nampt-IN-3 |
Nampt-IN-3 |
2121591-52-2 |
詳細(xì)
|
| NMS-P515 |
NMS-P515 |
1262395-13-0 |
詳細(xì)
|
| Neocryptotanshinone |
新隱丹參酮 |
109664-02-0 |
詳細(xì)
|
| NCGC00244536 |
3-(8-羥基喹啉-6-基)-N-(3-苯基丙基)苯甲酰胺 |
2003260-55-5 |
詳細(xì)
|
| Nicodicosapent |
1269181-69-2 |
1269181-69-2 |
詳細(xì)
|
| NucPE1 |
1404091-23-1 |
1404091-23-1 |
詳細(xì)
|
| Naphthoquine phosphate |
磷酸萘酚喹 |
173531-58-3 |
詳細(xì)
|
| NaV1.7 inhibitor-1 |
NaV1.7 inhibitor-1 |
1494585-79-3 |
詳細(xì)
|
| NRP1 antagonist 1 |
化合物 NRP1 ANTAGONIST 1 |
2569598-01-0 |
詳細(xì)
|
| Niga-ichigoside F1 |
苦莓苷F1 |
95262-48-9 |
詳細(xì)
|
| Nodosin |
諾多星 |
10391-09-0 |
詳細(xì)
|
| Nelociguat |
N-[4,6-二氨基-2-[1-[(2-氟苯基)甲基]-1H-吡唑并[3,4-B]吡啶-3-基]-5-嘧啶]-氨基甲酸甲酯 |
625115-52-8 |
詳細(xì)
|
| NCRW0005-F05 |
化合物NCRW0005-F05 |
342779-66-2 |
詳細(xì)
|
| NVX-207 |
745020-66-0 |
745020-66-0 |
詳細(xì)
|
| NMDI14 |
NMDI14 |
307519-88-6 |
詳細(xì)
|
| NHWD-870 |
化合物NHWD-870 |
2115742-03-3 |
詳細(xì)
|
| N-β-alanyldopamine hydrochloride |
3-氨基-N-(3,4-二羥基苯乙基)丙酰胺鹽酸鹽 |
58077-93-3 |
詳細(xì)
|
| Nuvenzepine |
奴文西平 |
96487-37-5 |
詳細(xì)
|
| NSC 694623 |
化合物 NSC 694623 |
907957-34-0 |
詳細(xì)
|
| NK1 receptor antagonist 2 |
化合物 NK1 RECEPTOR ANTAGONIST 2 |
579475-17-5 |
詳細(xì)
|
| N-Feruloyloctopamine |
N-阿魏酰章魚胺 |
66648-44-0 |
詳細(xì)
|
| N-(3-Methoxybenzyl)Palmitamide |
瑪卡酰胺雜質(zhì)5 |
847361-96-0 |
詳細(xì)
|
| N-Desethyl amodiaquine dihydrochloride |
去乙基阿莫地喹鹽酸鹽 |
79049-30-2 |
詳細(xì)
|
| Niraparib (R-enantiomer) |
MK-4827 (R-enantioMer) |
1038915-58-0 |
詳細(xì)
|
| N-deacetylated BMS-202 |
N-deacetylated BMS-202 |
2310135-18-1 |
詳細(xì)
|
| Neoseptin 3 |
1622863-21-1 |
1622863-21-1 |
詳細(xì)
|
| NCGC00029283 |
3-(5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl)-6-methoxyquinolin-2(1H)-one |
714240-31-0 |
詳細(xì)
|
| NH-3 |
化合物NH-3 |
447415-26-1 |
詳細(xì)
|
| NF-56-EJ40 |
NF-56-EJ40 |
2380230-73-7 |
詳細(xì)
|
| Nav1.1 activator 1 |
Nav1.1 activator 1 |
2332897-85-3 |
詳細(xì)
|
| N7-Methyl-guanosine-5'-triphosphate-5'-adenosine diammonium |
|
75252-10-7 |
詳細(xì)
|
| NSC 694621 |
化合物 ISOTHIAZOLO[5,4-B]PYRIDIN-3(2H)-ONE, 2-(4-METHOXYPHENYL)- |
104857-29-6 |
詳細(xì)
|
| Nitecapone |
硝替卡朋 |
116313-94-1 |
詳細(xì)
|
| N1,N3,N5-Tris(4-dodecylhexadecyl)benzene-1,3,5-tricarboxamide |
N1,N3,N5-三(4-十二烷基十六烷基)苯-1,3,5-三甲酰胺 |
2922283-38-1 |
詳細(xì)
|
| N-p-trans-Coumaroyltyramine |
N-反式-對香豆酰酪胺 |
36417-86-4 |
詳細(xì)
|
| NPPM 6748-481 |
(4-Chloro-3-nitrophenyl)(4-(2-fluorophenyl)piperazin-1-yl)Methanone |
432020-20-7 |
詳細(xì)
|
| NMS-P715 |
NMS-P715 |
1202055-32-0 |
詳細(xì)
|
| Nampt-IN-1 |
2-羥基-2-甲基-N-[1,2,3,4-四氫-2-[2-(3-吡啶基氧基)乙?；鵠-6-異喹啉基]-1-丙烷磺酰胺 |
1698878-14-6 |
詳細(xì)
|
| N6-(4-Hydroxybenzyl)adenosine |
PARA-TOPOLIN RIBOSIDE |
110505-75-4 |
詳細(xì)
|
| NHS-SS-Ph |
化合物 NHS-SS-PH |
2750799-12-1 |
詳細(xì)
|
| NRX-2663 |
化合物 NRX-2663 |
2763260-34-8 |
詳細(xì)
|
| NCI172112 |
螺莫司汀 |
56605-16-4 |
詳細(xì)
|
| Nrf2 activator-4 |
化合物 NRF2 ACTIVATOR-4 |
2383016-68-8 |
詳細(xì)
|
| Nevadensin |
5,7-二羥基-6,8,4'-三甲氧基黃酮 |
10176-66-6 |
詳細(xì)
|
| Naquotinib mesylate |
ASP-8273 |
1448237-05-5 |
詳細(xì)
|
| Norwogonin |
5,7,8-三羥基黃酮 |
4443-09-8 |
詳細(xì)
|
| NRX-252262 |
化合物NRX-252262 |
2438637-61-5 |
詳細(xì)
|
| NPD-1335 |
化合物 T12250 |
2376326-31-5 |
詳細(xì)
|
| (Rac)-NMDAR antagonist 1 |
化合物 (RAC)-NMDAR ANTAGONIST 1 |
2435557-99-4 |
詳細(xì)
|
| NF-κB/MAPK-IN-1 |
化合物 NF-ΚB/MAPK-IN-1 |
2413940-56-2 |
詳細(xì)
|
| Necroptosis-IN-1 |
5-(7-Chloro-1H-indol-3-ylMethyl)-iMidazolidine-2,4-dione |
1391980-92-9 |
詳細(xì)
|
| Niclosamide-13C6 |
氯硝柳胺-13C6-水合物 |
1325808-64-7 |
詳細(xì)
|
| N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide |
(9Z,12Z,15Z)-N-[(3-甲氧基苯基)甲基]-9,12,15-十八碳三烯酰胺 |
883715-23-9 |
詳細(xì)
|
| Naproxen etemesil |
(S)-2-(甲磺酰)乙基 2-(6-甲氧基萘-2-基)丙酯 |
385800-16-8 |
詳細(xì)
|
| [Leu31,Pro34]-Neuropeptide Y (porcine) |
[LEU 31, PRO34]-神經(jīng)肽Y(豬) |
125580-28-1 |
詳細(xì)
|
| NCT-506 |
NCT-506 |
2231098-99-8 |
詳細(xì)
|
| N-[(4-Aminophenyl)methyl]adenosine |
N-[(4-氨基苯基)甲基]腺苷 |
95523-13-0 |
詳細(xì)
|
| Navitoclax-piperazine |
ABT-263-piperazine |
2143096-93-7 |
詳細(xì)
|
| Narmafotinib |
AMP-945 |
1393653-34-3 |
詳細(xì)
|
| NCT02 |
2-{5H,6H,7H-茚并[5,6-B]呋喃-3-基}-N-(5-甲基-1,3-噻唑-2-基)乙酰胺 |
790245-61-3 |
詳細(xì)
|
| N-ε-propargyloxycarbonyl-L-lysine hydrochloride |
N-Ε-炔丙氧基羰基-L-賴氨酸鹽酸鹽 |
1428330-91-9 |
詳細(xì)
|
| NAI-N3 |
1612756-29-2 |
1612756-29-2 |
詳細(xì)
|
| Nucleoprotein (396-404) |
NUCLEOPROTEIN 396-404;NP 396 |
158475-79-7 |
詳細(xì)
|
| Nigranoic acid |
NIGRANOIC ACID |
39111-07-4 |
詳細(xì)
|
| NSC 601980 |
化合物 T12259 |
2070018-27-6 |
詳細(xì)
|
| NFATc1-IN-1 |
化合物 NFATC1-IN-1 |
1912422-56-0 |
詳細(xì)
|
| NUCC-390 dihydrochloride |
化合物 NUCC-390 DIHYDROCHLORIDE |
2749281-71-6 |
詳細(xì)
|
| Nagilactone B |
竹柏內(nèi)酯 B |
19891-51-1 |
詳細(xì)
|
| Nigakinone |
苦木堿乙 |
18110-86-6 |
詳細(xì)
|
| Notoginsenoside R2 |
三七皂苷R2 |
80418-25-3 |
詳細(xì)
|
| N-acetyl Dapsone-d4 |
N-acetyl Dapsone D4 |
2070015-08-4 |
詳細(xì)
|
| Niraparib metabolite M1 |
尼拉帕尼代謝物 M1 |
1476777-06-6 |
詳細(xì)
|
| NLRP3-IN-13 |
NLRP3 抑制劑 13 |
1704638-35-6 |
詳細(xì)
|
| NS3861 |
化合物NS3861 |
216853-59-7 |
詳細(xì)
|